Cost Consequences of Surveillance, Medical Management or Surgery for Benign Prostatic Hyperplasia
- 1 April 1996
- journal article
- Published by Wolters Kluwer Health in Journal of Urology
- Vol. 155 (4) , 1311-1316
- https://doi.org/10.1016/s0022-5347(01)66254-2
Abstract
No abstract availableThis publication has 10 references indexed in Scilit:
- THE AGENCY FOR HEALTH CARE POLICY AND RESEARCHUrologic Clinics of North America, 1995
- Urologists On a Tightrope: Coping with a Changing EconomyJournal of Urology, 1994
- Discounting in the Economic Evaluation of Health Care InterventionsMedical Care, 1993
- The costs of prostatectomy for benign prostatic hyperplasiaThe Prostate, 1993
- Epidemiology of Bladder Emptying Symptoms in Elderly MenJournal of Urology, 1992
- A Randomized, Placebo-Controlled Multicenter Study of the Efficacy and Safety of Terazosin in the Treatment of Benign Prostatic HyperplasiaJournal of Urology, 1992
- Perspective: AHCPR and the Strategy for Health Care ReformHealth Affairs, 1992
- Watchful waiting vs immediate transurethral resection for symptomatic prostatism. The importance of patients' preferencesJAMA, 1988
- Use of claims data systems to evaluate health care outcomes. Mortality and reoperation following prostatectomyJAMA, 1987
- The placebo effect. A neglected asset in the care of patientsPublished by American Medical Association (AMA) ,1975